Wealthfront Advisers’s Biogen BIIB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.09M | Buy |
8,684
+4,899
| +129% | +$615K | ﹤0.01% | 664 |
|
2025
Q1 | $518K | Buy |
3,785
+1,949
| +106% | +$267K | ﹤0.01% | 773 |
|
2024
Q4 | $281K | Sell |
1,836
-1,316
| -42% | -$201K | ﹤0.01% | 844 |
|
2024
Q3 | $611K | Sell |
3,152
-371
| -11% | -$71.9K | ﹤0.01% | 736 |
|
2024
Q2 | $817K | Sell |
3,523
-2,138
| -38% | -$496K | ﹤0.01% | 662 |
|
2024
Q1 | $1.22M | Sell |
5,661
-271
| -5% | -$58.4K | ﹤0.01% | 576 |
|
2023
Q4 | $1.54M | Buy |
5,932
+332
| +6% | +$85.9K | 0.01% | 512 |
|
2023
Q3 | $1.44M | Sell |
5,600
-4,941
| -47% | -$1.27M | 0.01% | 488 |
|
2023
Q2 | $3M | Buy |
10,541
+205
| +2% | +$58.4K | 0.01% | 325 |
|
2023
Q1 | $2.87M | Buy |
10,336
+3,825
| +59% | +$1.06M | 0.01% | 331 |
|
2022
Q4 | $1.8M | Buy |
6,511
+133
| +2% | +$36.8K | 0.01% | 427 |
|
2022
Q3 | $1.7M | Buy |
6,378
+1,869
| +41% | +$499K | 0.01% | 397 |
|
2022
Q2 | $920K | Sell |
4,509
-5,526
| -55% | -$1.13M | ﹤0.01% | 499 |
|
2022
Q1 | $2.11M | Buy |
10,035
+7,508
| +297% | +$1.58M | 0.01% | 387 |
|
2021
Q4 | $606K | Sell |
2,527
-8,077
| -76% | -$1.94M | ﹤0.01% | 565 |
|
2021
Q3 | $3M | Sell |
10,604
-169
| -2% | -$47.8K | 0.01% | 253 |
|
2021
Q2 | $3.73M | Buy |
10,773
+1,572
| +17% | +$544K | 0.02% | 172 |
|
2021
Q1 | $2.57M | Buy |
9,201
+2,872
| +45% | +$803K | 0.01% | 213 |
|
2020
Q4 | $1.55M | Buy |
6,329
+550
| +10% | +$135K | 0.01% | 286 |
|
2020
Q3 | $1.64M | Sell |
5,779
-2,154
| -27% | -$611K | 0.01% | 222 |
|
2020
Q2 | $2.12M | Sell |
7,933
-1,974
| -20% | -$528K | 0.02% | 156 |
|
2020
Q1 | $3.13M | Buy |
9,907
+1,265
| +15% | +$400K | 0.03% | 95 |
|
2019
Q4 | $2.56M | Buy |
8,642
+3,986
| +86% | +$1.18M | 0.02% | 136 |
|
2019
Q3 | $1.08M | Buy |
4,656
+201
| +5% | +$46.8K | 0.01% | 278 |
|
2019
Q2 | $1.04M | Buy |
4,455
+2,658
| +148% | +$622K | 0.01% | 267 |
|
2019
Q1 | $425K | Sell |
1,797
-7,201
| -80% | -$1.7M | ﹤0.01% | 382 |
|
2018
Q4 | $2.71M | Buy |
+8,998
| New | +$2.71M | 0.03% | 100 |
|